TrialAdvances in therapy2024

Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Mark Boguniewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.